A Study of AL8326 in Healthy Subjects

NCT07132957 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer
Solid Tumors

Interventions

DRUG: 14C-labeled AL8326

Sponsor

Advenchen Laboratories Nanjing Ltd.